Gabriele Ciceri, Hyunwoo Cho, Meghana Kshirsagar, Arianna Baggiolini, Kelly A Aromolaran, Ryan M Walsh, Peter A Goldstein, Richard P Koche, Christina S Leslie, Lorenz Studer
The Liver4Life research team owes its perfusion machine, which was developed in house, to the fact that it became possible to implant a human organ into a patient after a storage period of three days outside a body.
An innovative artificial enzyme has shown it can chew through woody lignin, an abundant carbon-based substance that stores tremendous potential for renewable energy and materials.
Blake T Darkow, Joseph P Herbert, Mark J Messler, Abigail Grisolano, August J Hemmerla, Austin D Kimes, Julien Lanza, Yisheng Sun, Julia R Crim, Derek Stensby, Caixia Wan, Don K Moore, Bret D Ulery
Alec B Chaves, Donghai Zheng, Jonathan A Johnson, Bryan C Bergman, Zachary W Patinkin, Vincent Zaegel, Ericka M Biagioni, Polina Krassovskaia, Nicholas T Broskey, Linda E May, Dana Dabelea, Joseph A Houmard, Kristen E Boyle
Poor healing of cutaneous wounds is a common medical problem in the field of traumatology. Due to the intricate pathophysiological processes of wound healing, the use of conventional treatment methods, such as chemical molecule drugs and tradit
BACKGROUNDDiabetes mellitus (DM) is a serious and growing global health burden. It is estimated that 80% of diabetic patients have micturition problems such as poor emptying, urinary incontinence, urgency, and urgency incontinence. Patients wit
BACKGROUNDHuman Wharton’s jelly-derived mesenchymal stromal/stem cells (hWJ-MSCs) have gained considerable attention in their applications in cell-based therapy due to several advantages offered by them. Recently, we reported that hWJ-MSCs an
Pharmacological inhibitors of glutathione synthesis and circulation, such as buthionine-sulfoximine, inhibit glutathione metabolism. These drugs decrease the aggressiveness of pancreatic cancer, inhibit tumor stem cell survival, and reduce chem
Hypomethylating agents (HMA) are currently used as a first-line treatment for patients with myelodysplastic syndrome (MDS) - a group of disorders where there is insufficient production of healthy mature blood cells in the bone marrow - and increasingly in other diseases, but their mechanism of action remains unclear.
Prilenia Therapeutics B.V., a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative and neurodevelopmental disorders, today announced publication of its research in the peer-reviewed journal Autophagy which support pridopidine’s potential neuroprotective properties by enhancing autophagy in an amyotrophic lateral sclerosis (ALS) model.
A stomach adult stem cell population can fulfill two distinct functions: either help with digestion under normal conditions or take the lead on injury response.
Seven new innovators representing five clean energy startups will join Chain Reaction Innovations, Argonne National Laboratory’s entrepreneurship program, as part of the elite program’s sixth cohort.